SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news

 

 
News in brief

DSM says acqusition of formulator Fortitech has no Pharma implications

08-Nov-2012

DSM says acquisition of food formulation technology firm wont impact its pharmaceutical business.

The Netherlands-based firm announced the $634m (€495m) tackeover of Fortitech earlier today, explaining the US firm’s range of formulation technologies will expand its offering to the food, beverage and nutritional.

In-Pharmatechnologist.com asked DSM if the deal, which is expected to close before the end of the year, had any implications for its pharmaceutical business given Firtitech’s formulation expertise.

However, according to spokesman Herman Betten the businesses are separate businesses.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions